Livermore

Birchview Capital, LP

SEC CIK
0001618205

Holdings, Q2 2026

Positions as of Jun 30, 2026, filed Aug 14, 2026.SEC

Positions
72
−1 vs. Q1 2026
Total value
$213.83M
+$38.16M (+21.7%) vs. Q1 2026

Compare with Q1 2026: new, added, reduced and sold out

Positions

Long positions only. Changes compare share counts with Q1 2026.

Birchview Capital, LP holdings in Q2 2026
SecurityClassSharesValue% of portfolioChange in sharesActionHistory
KLACKLA CORPCOM NEW178,471$53.85M25.18%+158,588+797.6%AddedView
BMYBRISTOL-MYERS SQUIBB CO COMStock297,243$17.13M8.01%−9,025−2.9%ReducedView
LRCXLAM RESEARCH CORP COM NEWStock35,000$15.17M7.09%−1,000−2.8%ReducedView
NTLAINTELLIA THERAPEUTICS INCCOM385,900$6.78M3.17%−59,500−13.4%ReducedView
SLDBSOLID BIOSCIENCES INCCOM NEW666,196$6.66M3.11%+40,216+6.4%AddedView
BDSXBIODESIX INCCOM286,804$6.47M3.02%00.0%UnchangedView
STOKSTOKE THERAPEUTICS INCCOM178,110$5.83M2.73%−31,890−15.2%ReducedView
OVVOVINTIV INCCOM107,500$5.66M2.65%00.0%UnchangedView
NKTRNEKTAR THERAPEUTICSCOM NEW81,000$5.65M2.64%+50,000+161.3%AddedView
CORTCORCEPT THERAPEUTICS INCCOM57,200$4.97M2.33%+10,000+21.2%AddedView
NBIXNEUROCRINE BIOSCIENCES INC COMStock27,190$4.58M2.14%00.0%UnchangedView
PRTAPROTHENA CORP PLCSHS449,019$4.4M2.06%00.0%UnchangedView
ACADACADIA PHARMACEUTICALS INCCOM171,000$4.33M2.02%00.0%UnchangedView
PTGXPROTAGONIST THERAPEUTICS INCCOM35,018$4.29M2.01%+18+0.1%AddedView
CMPXCOMPASS THERAPEUTICS INCCOM1,675,000$3.67M1.72%+209,133+14.3%AddedView
RLMDRELMADA THERAPEUTICS INCCOM408,100$2.82M1.32%−1,287−0.3%ReducedView
ALKSALKERMES PLCSHS50,000$2.62M1.23%00.0%UnchangedView
HALOHALOZYME THERAPEUTICS INCCOM33,251$2.6M1.22%+23,151+229.2%AddedView
CLDXCELLDEX THERAPEUTICS INC NEWCOM NEW69,900$2.6M1.22%−195−0.3%ReducedView
CYTKCYTOKINETICS INCCOM NEW30,000$2.56M1.20%00.0%UnchangedView
OLMAOLEMA PHARMACEUTICALS INCCOM199,000$2.49M1.16%−20,000−9.1%ReducedView
VERAVERA THERAPEUTICS INCCL A57,758$2.48M1.16%+13,758+31.3%AddedView
UTHRUNITED THERAPEUTICS CORP DELCOM4,506$2.44M1.14%+6+0.1%AddedView
ZBIOZENAS BIOPHARMA INCCOM93,601$2.38M1.11%+23,601+33.7%AddedView
QUREUNIQURE NVSHS50,697$2.34M1.09%−50,000−49.7%ReducedView
PACBPACIFIC BIOSCIENCES CALIF INCOM1,350,000$2.27M1.06%−150,000−10.0%ReducedView
ABVXABIVAX SASPONSORED ADS17,000$2.27M1.06%+17,000NewView
VIRVIR BIOTECHNOLOGY INCCOM220,000$2.24M1.05%+220,000NewView
BIIBBIOGEN INCCOM9,000$1.94M0.91%+4,000+80.0%AddedView
EQTEQT CORP COMStock34,619$1.84M0.86%00.0%UnchangedView
BIOABIOAGE LABS INCCOM69,000$1.69M0.79%+69,000NewView
TVTXTRAVERE THERAPEUTICS INCCOM29,000$1.65M0.77%−200−0.7%ReducedView
QDELQUIDEL CORPCOM89,377$1.57M0.73%+6,829+8.3%AddedView
AXSMAXSOME THERAPEUTICS INC.COM6,000$1.47M0.69%00.0%UnchangedView
FHTXFOGHORN THERAPEUTICS INCCOM281,937$1.38M0.64%+207+0.1%AddedView
BCYCBICYCLE THERAPEUTICS PLCSPONSORED ADS313,616$1.33M0.62%−149,983−32.4%ReducedView
GPCRSTRUCTURE THERAPEUTICS INCSPONSORED ADS24,000$1.29M0.60%−76,000−76.0%ReducedView
XENEXENON PHARMACEUTICALS INCCOM21,032$1.27M0.59%+32+0.2%AddedView
NVONOVO-NORDISK A S ADRADR24,000$1.15M0.54%+24,000NewView
FCXFREEPORT MCMORAN INC CL BStock18,035$1.13M0.53%−50.0%ReducedView
IMNMIMMUNOME INCCOM50,000$1.06M0.50%00.0%UnchangedView
PHVSPHARVARIS N VCOM29,847$1.03M0.48%00.0%UnchangedView
HROWHARROW INCCOM24,000$1.02M0.48%00.0%UnchangedView
ADAGADAGENE INCADS240,000$1.01M0.47%+240,000NewView
DFTXDEFINIUM THERAPEUTICS INCCOM SHS20,000$940.8K0.44%+20,000NewView
SLNSILENCE THERAPEUTICS PLCADS71,218$781.97K0.37%+71,218NewView
BBIOBRIDGEBIO PHARMA INCCOM8,741$651.03K0.30%+53+0.6%AddedView
FDMT4D MOLECULAR THERAPEUTICS INCOM48,505$645.12K0.30%+48,505NewView
URGNUROGEN PHARMA LTDCOM16,487$606.72K0.28%+16,487NewView
PHATPHATHOM PHARMACEUTICALS INCCOM55,000$596.75K0.28%−140,000−71.8%ReducedView
CAMPCAMP4 THERAPEUTICS CORPCOM120,000$524.4K0.25%+120,000NewView
SVRASAVARA INCCOM80,000$492.8K0.23%+80,000NewView
CADLCANDEL THERAPEUTICS INCCOM47,756$491.89K0.23%−12,244−20.4%ReducedView
ALTALTIMMUNE INCCOM NEW152,681$464.15K0.22%+152,681NewView
CMPSCOMPASS PATHWAYS PLCSPONSORED ADS30,000$424.5K0.20%−345,000−92.0%ReducedView
KPTIKARYOPHARM THERAPEUTICS INCCOM42,952$419.64K0.20%−41,000−48.8%ReducedView
CGEMCULLINAN THERAPEUTICS INCCOM20,000$364.2K0.17%00.0%UnchangedView
TRINTRINITY CAP INCCOM20,000$357.8K0.17%00.0%UnchangedView
CAPRCAPRICOR THERAPEUTICS INCCOM NEW14,352$345.6K0.16%+14,352NewView
CSTLCASTLE BIOSCIENCES INCCOM12,984$309.67K0.14%+84+0.7%AddedView
IVVDINVIVYD INCCOM342,275$298.6K0.14%+342,275NewView
GRCEACASTI PHARMA INCCL A120,000$272.4K0.13%+70,000+140.0%AddedView
KBDCKAYNE ANDERSON BDC INCCOM SHS20,000$270.6K0.13%00.0%UnchangedView
VYGRVOYAGER THERAPEUTICS INCCOM75,147$263.02K0.12%+229+0.3%AddedView
LUNGPULMONX CORPCOM200,543$260.71K0.12%−49,678−19.9%ReducedView
OCULOCULAR THERAPEUTIX INCCOM20,655$202.83K0.09%−299,345−93.5%ReducedView
KYNBKYNTRA BIO INCCOM NEW22,566$170.37K0.08%00.0%UnchangedView
ELUTELUTIA INCCL A COM165,094$161.73K0.08%00.0%UnchangedView
QNRXQuoin Pharmaceuticals Ltd ADRADR20,000$96.8K0.05%00.0%UnchangedView
LPCNLIPOCINE INC NEWCOM NEW16,712$42.78K0.02%−95,074−85.1%ReducedView
DCGODOCGO INCCOM39,062$20.16K0.01%−511−1.3%ReducedView
GOSSGOSSAMER BIO INCCOM18,176$2.99K0.00%00.0%UnchangedView

Sold out since Q1 2026 (15)

Positions held at the end of Q1 2026 that are no longer in this filing.

Birchview Capital, LP positions sold out since Q1 2026
SecurityClassShares, Q1 2026Value, Q1 2026% of portfolio, Q1 2026
NVCRNOVOCURE LTDORD SHS202,330$2.21M1.26%
ENGNENGENE HOLDINGS INCCOM250,000$1.7M0.97%
RAREULTRAGENYX PHARMACEUTICAL INCOM62,000$1.3M0.74%
KALVISTA PHARMACEUTICALS INC483497103COM57,000$1.15M0.65%
VSTMVERASTEM INCCOM NEW150,000$795K0.45%
APOGEE THERAPEUTICS INC03770N101COM9,000$757.53K0.43%
APELLIS PHARMACEUTICALS INC03753U106COM14,000$563.22K0.32%
IDYAIDEAYA BIOSCIENCES INCCOM16,860$561.78K0.32%
RCUSARCUS BIOSCIENCES INCCOM25,889$559.2K0.32%
RGNXREGENXBIO INCCOM66,270$555.34K0.32%
RCKTROCKET PHARMACEUTICALS INCCOM127,025$454.75K0.26%
VRDNVIRIDIAN THERAPEUTICS INCCOM20,100$393.16K0.22%
OMOUTSET MED INCCOM98,882$379.71K0.22%
PHRPHREESIA INCCOM14,300$119.83K0.07%
ZNTLZENTALIS PHARMACEUTICALS INCCOM17,503$40.96K0.02%

13F filings by quarter

Birchview Capital, LP 13F filings by quarter
QuarterFiledPositionsTotal valueChangesFiling
Q2 2026Aug 14, 202672$213.83Mvs. Q1 2026SEC
Q1 2026May 15, 202673$175.66Mvs. Q4 2025SEC
Q4 2025Feb 13, 202668$170.8Mvs. Q3 2025SEC
Q3 2025Nov 13, 202569$132.45Mvs. Q2 2025SEC
Q2 2025Aug 14, 202571$100.7Mvs. Q1 2025SEC
Q1 2025May 15, 202568$115.17Mvs. Q4 2024SEC
Q4 2024Jun 30, 2025Amended68$245.58Mvs. Q3 2024SECSEC
Q3 2024Jun 30, 2025Amended61$230.71Mvs. Q2 2024SECSEC
Q2 2024Jun 30, 2025Amended60$216.16Mvs. Q1 2024SECSEC
Q1 2024Jun 30, 2025Amended59$245.18Mvs. Q4 2023SECSEC
Q4 2023Jun 30, 2025Amended58$255.36Mvs. Q3 2023SECSEC
Q3 2023Jun 30, 2025Amended51$235.2Mvs. Q2 2023SECSEC
Q2 2023Aug 8, 202354$133.41Mvs. Q1 2023SEC
Q1 2023May 12, 202355$127.73Mvs. Q4 2022SEC
Q4 2022Feb 3, 202357$141.57Mvs. Q3 2022SEC
Q3 2022Nov 28, 2022Amended60$142.01Mvs. Q2 2022SEC
Q2 2022Aug 12, 202260$137.48Mvs. Q1 2022SEC
Q1 2022May 13, 202263$138.9Mvs. Q4 2021SEC
Q4 2021Feb 14, 202267$155.07Mvs. Q3 2021SEC
Q3 2021Nov 12, 202164$146.96Mvs. Q2 2021SEC
Q2 2021Aug 10, 202162$167.18Mvs. Q1 2021SEC
Q1 2021May 14, 202154$168.45M–SEC